Arkema Acquires Majority Stake in AEC Polymers

Arkema has acquired a majority stake in AEC Polymers, a French manufacturer of structural adhesives. AEC Polymers recently developed a range of methacrylate glues (SAF range) based on an Arkema technology. AEC Polymers will join the Group's new products and new technologies incubator.

Structural adhesives are increasingly used in industry to assemble composite materials, plastics, glass and metals. In the example of metals, the properties obtained are equivalent or superior to welding.

Growth in the structural adhesives market is driven by the quest for lighter materials used in transport (automotive, aerospace, shipbuilding, etc.), the increasing role of plastics in electronics and household electricals (miniaturization), and the development of wind power and alternative energies.

AEC Polymers was created in 2003, employs 25 people near Bordeaux (France), and manufactures a range of methacrylatebased structural adhesives (two-component adhesives based on an Arkema technology) and MS polymers (sealants curable at ambient moisture). It reports sales of €3.5 million.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.